Home > Share Market > Stocks > Biocon > Financial Statements > BIOCON Key Financial Ratios

Biocon Financial Statements

Biocon Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 11.60 54.40 5.97 16.20
Op profit growth 3.09 93.40 (15) 27.60
EBIT growth (1.70) 80.50 (22) 43.60
Net profit growth (1) 101 (39) 11.20
Profitability ratios (%)        
OPM 23.30 25.20 20.10 25.20
EBIT margin 16.80 19 16.30 22.10
Net profit margin 10.40 11.80 9.03 15.70
RoCE 10.30 13.40 8.60 11.90
RoNW 2.58 3.15 1.86 3.45
RoA 1.60 2.06 1.19 2.12
Per share ratios ()        
EPS 7.05 7.26 7.55 34.40
Dividend per share -- -- 1 3
Cash EPS 0.21 1.63 (0.20) 16.70
Book value per share 63.60 55.90 86.30 242
Valuation ratios        
P/E 58 37.30 39.40 5.49
P/CEPS 1,931 166 (1,404) 11.30
P/B 6.43 4.84 3.44 0.78
EV/EBIDTA 27 19.40 34.60 21.10
Payout (%)        
Dividend payout -- -- 16.10 9.80
Tax payout (20) (27) (26) (19)
Liquidity ratios        
Debtor days 62.70 65.60 86.20 74.90
Inventory days 84.80 61.90 60.10 55.20
Creditor days (122) (114) (120) (110)
Leverage ratios        
Interest coverage (21) (19) (11) (33)
Net debt / equity 0.32 0.26 0.18 0.26
Net debt / op. profit 1.49 1.07 1.14 1.28
Cost breakup ()        
Material costs (31) (32) (40) (37)
Employee costs (25) (23) (23) (19)
Other costs (21) (20) (18) (18)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits worth 10,000